Literature DB >> 8013497

In vitro activity of rifaximin against Helicobacter pylori.

F Mégraud, F Bouffant, C Camou Juncas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8013497     DOI： 10.1007/bf01982198

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  15 in total

1.  Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics.

Authors:  W SZYBALSKI; V BRYSON
Journal:  J Bacteriol       Date:  1952-10       Impact factor: 3.490

Review 2.  [Treatment of chronic gastritis associated with Campylobacter pylori].

Authors:  H Lamouliatte
Journal:  Gastroenterol Clin Biol       Date:  1989

Review 3.  Helicobacter pylori and duodenal ulcer. Evidence suggesting causation.

Authors:  F Mégraud; H Lamouliatte
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

4.  Activity of lansoprazole against Helicobacter pylori.

Authors:  F Megraud; L Boyanova; H Lamouliatte
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

5.  In vitro selection of resistant Helicobacter pylori.

Authors:  C E Haas; D E Nix; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents.

Authors:  M L Grayson; G M Eliopoulos; M J Ferraro; R C Moellering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

7.  Treatment of small intestine bacterial overgrowth with rifaximin, a non-absorbable rifamycin.

Authors:  G R Corazza; M Ventrucci; A Strocchi; M Sorge; L Pranzo; R Pezzilli; G Gasbarrini
Journal:  J Int Med Res       Date:  1988 Jul-Aug       Impact factor: 1.671

Review 8.  Drug therapy for Helicobacter pylori infection: problems and pitfalls.

Authors:  Y Glupczynski; A Burette
Journal:  Am J Gastroenterol       Date:  1990-12       Impact factor: 10.864

9.  Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori.

Authors: 
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

10.  Cure of duodenal ulcer associated with eradication of Helicobacter pylori.

Authors:  E A Rauws; G N Tytgat
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321
View more
  2 in total

1.  Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori.

Authors:  Sang-Pil Yun; Han Gyung Seon; Chang Soo Ok; Kwang Ho Yoo; Min Kyung Kang; Won Hee Kim; Chang Il Kwon; Kwang Hyun Ko; Seong Gyu Hwang; Pil Won Park; Sung Pyo Hong
Journal:  Gut Liver       Date:  2012-10-18       Impact factor: 4.519

2.  Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection.

Authors:  Paulina Konrad; Jan Chojnacki; Anita Gąsiorowska; Cezary Rudnicki; Aleksandra Kaczka; Cezary Chojnacki
Journal:  Prz Gastroenterol       Date:  2018-03-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.